Repeat drug-coated balloon angioplasty for femoropopliteal lesions: 12-month results from a retrospective observational study
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
Repeat drug-coated balloon angioplasty for femoropopliteal lesions: 12-month results from a retrospective observational study ; volume:7 ; number:1 ; day:29 ; month:2 ; year:2024 ; pages:1-11 ; date:12.2024
CVIR endovascular ; 7, Heft 1 (29.2.2024), 1-11, 12.2024
- Urheber
-
Haraguchi, Takuya
Tsujimoto, Masanaga
Kashima, Yoshifumi
Sato, Katsuhiko
Fujita, Tsutomu
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s42155-024-00434-w
- URN
-
urn:nbn:de:101:1-2405070853456.250423084797
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:51 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Haraguchi, Takuya
- Tsujimoto, Masanaga
- Kashima, Yoshifumi
- Sato, Katsuhiko
- Fujita, Tsutomu
- SpringerLink (Online service)
Ähnliche Objekte (12)
Impact of Chocolate percutaneous transluminal angioplasty balloon on vessel preparation in drug-coated balloon angioplasty for femoropopliteal lesion
Three-year sustained clinical efficacy of drug-coated balloon angioplasty in a real-world femoropopliteal cohort
Rotarex®S rotational atherectomy combined with drug-coated balloon angioplasty for treating femoropopliteal artery in-stent restenosis
Multivariable Regression Analysis of Clinical Data from the Randomized-Controlled EffPac Trial: Efficacy of Femoropopliteal Drug-Coated Balloon Angioplasty
Comparison of mid-outcome among bare metal stent, atherectomy with or without drug-coated balloon angioplasty for femoropopliteal arterial occlusion
Determinants of drug-coated balloon failure in patients undergoing femoropopliteal arterial intervention
Long-Term Effectiveness and Safety of Femoropopliteal Drug-Coated Balloon Angioplasty : 5-Year Results of the Randomized Controlled EffPac Trial
Long-term effectiveness and safety of femoropopliteal drug-coated balloon angioplasty : : 5-year results of the randomized controlled EffPac trial
Triglyceride-glucose index on risk of adverse events after drug-coated balloon angioplasty
Drug-coated balloon versus drug-eluting stent for femoropopliteal total occlusions: intraluminal versus subintimal approaches
Platelet to lymphocyte ratio predicting 6-month primary patency of drug-coated balloon for femoropopliteal disease
Drug-coated balloon treatment for femoropopliteal artery disease : : the IN.PACT global study long lesion imaging cohort
Impact of Chocolate percutaneous transluminal angioplasty balloon on vessel preparation in drug-coated balloon angioplasty for femoropopliteal lesion
Three-year sustained clinical efficacy of drug-coated balloon angioplasty in a real-world femoropopliteal cohort
Rotarex®S rotational atherectomy combined with drug-coated balloon angioplasty for treating femoropopliteal artery in-stent restenosis
Multivariable Regression Analysis of Clinical Data from the Randomized-Controlled EffPac Trial: Efficacy of Femoropopliteal Drug-Coated Balloon Angioplasty
Comparison of mid-outcome among bare metal stent, atherectomy with or without drug-coated balloon angioplasty for femoropopliteal arterial occlusion
Determinants of drug-coated balloon failure in patients undergoing femoropopliteal arterial intervention
Long-Term Effectiveness and Safety of Femoropopliteal Drug-Coated Balloon Angioplasty : 5-Year Results of the Randomized Controlled EffPac Trial
Long-term effectiveness and safety of femoropopliteal drug-coated balloon angioplasty : : 5-year results of the randomized controlled EffPac trial
Triglyceride-glucose index on risk of adverse events after drug-coated balloon angioplasty
Drug-coated balloon versus drug-eluting stent for femoropopliteal total occlusions: intraluminal versus subintimal approaches
Platelet to lymphocyte ratio predicting 6-month primary patency of drug-coated balloon for femoropopliteal disease
Drug-coated balloon treatment for femoropopliteal artery disease : : the IN.PACT global study long lesion imaging cohort
Impact of Chocolate percutaneous transluminal angioplasty balloon on vessel preparation in drug-coated balloon angioplasty for femoropopliteal lesion
Three-year sustained clinical efficacy of drug-coated balloon angioplasty in a real-world femoropopliteal cohort
Rotarex®S rotational atherectomy combined with drug-coated balloon angioplasty for treating femoropopliteal artery in-stent restenosis
Multivariable Regression Analysis of Clinical Data from the Randomized-Controlled EffPac Trial: Efficacy of Femoropopliteal Drug-Coated Balloon Angioplasty
Comparison of mid-outcome among bare metal stent, atherectomy with or without drug-coated balloon angioplasty for femoropopliteal arterial occlusion
Determinants of drug-coated balloon failure in patients undergoing femoropopliteal arterial intervention
Long-Term Effectiveness and Safety of Femoropopliteal Drug-Coated Balloon Angioplasty : 5-Year Results of the Randomized Controlled EffPac Trial
Long-term effectiveness and safety of femoropopliteal drug-coated balloon angioplasty : : 5-year results of the randomized controlled EffPac trial
Triglyceride-glucose index on risk of adverse events after drug-coated balloon angioplasty
Drug-coated balloon versus drug-eluting stent for femoropopliteal total occlusions: intraluminal versus subintimal approaches
Platelet to lymphocyte ratio predicting 6-month primary patency of drug-coated balloon for femoropopliteal disease